Investment adviser · CRD 148467

MPM BIOIMPACT

Investment adviser filing (IA)

MPM ASSET MANAGEMENT LLC

BOSTON, MA, United States · Form ADV filed Apr 28, 2026

Regulatory AUM
$3.56B
Form ADV · Item 5.F
Client accounts
23
Accounts, not individual clients
Employees
50
Reported in this filing
Advisory professionals
27
Investment advisory functions

Who they report serving

Form ADV · Item 5.D

Client types and their share of reported regulatory assets.

Client typeClientsRegulatory assetsShare of AUM
Pooled investment vehicles23$3,558,119,290100.0%
Filing source

Form ADV 2098941 · Apr 28, 2026 · Item 5.D

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Private funds & service providers

39 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

ONCOLOGY IMPACT FUND 2, L.P.Other Private Fund · Last reported Apr 28, 2026$1BGross asset value

Form D fundraising filings

Oncology Impact Fund 2, L.P.

Feeder funds

  • ONCOLOGY IMPACT PRIVATE INVESTMENT FUND 2, L.P.
  • ONCOLOGY IMPACT PUBLIC INVESTMENT FUND 2, L.P.
Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG GRAND CAYMAN, Cayman Islands
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Fund details & source
Fund ID
805-6509560883
Reported beneficial owners
33
Minimum commitment
$5M
Form D file number
021-422030

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

UBS ONCOLOGY IMPACT FUND L.P.Other Private Fund · Last reported Apr 28, 2026$570MGross asset value

Feeder funds

  • UBS ONCOLOGY IMPACT FUND (CAYMAN) INVESTOR L.P.
  • UBS ONCOLOGY IMPACT FUND (CAYMAN) INVESTOR LTD.
Fund administrator MUFG FUND SERVICES HALIFAX, Canada Investor statements: Yes (provided to all investors) Related to adviser: No
Fund administrator UBS AG ST HELIER, New Jersey, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG GRAND CAYMAN, Cayman Islands
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian J.P. MORGAN SECURITIES LLC BOSTON, Massachusetts, United States Related to adviser: No
Custodian MORGAN STANLEY BOSTON, Massachusetts, United States Related to adviser: No
Custodian PERSHING LLC JERSEY CITY, New Jersey, United States Related to adviser: No
Custodian UBS AG ST HELIER, New Jersey, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

J.P. MORGAN SECURITIES LLC
SEC 8-35008

PERSHING LLC
SEC 8-17574

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Fund details & source
Fund ID
805-4135349827
Reported beneficial owners
660
Minimum commitment
$5M

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

MPM BIOVENTURES 2018, L.P.Venture Capital Fund · Last reported Apr 28, 2026$483MGross asset value

Form D fundraising filings

MPM BIOVENTURES 2018, L.P.

Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP BOSTON, Massachusetts, United States
Custodian J.P. MORGAN SECURITIES LLC BOSTON, Massachusetts, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

J.P. MORGAN SECURITIES LLC
SEC 8-35008

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

Fund details & source
Fund ID
805-9483444745
Reported beneficial owners
43
Minimum commitment
$100K
Form D file number
021-306245

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

MPM BIOVENTURES 2022, L.P.Venture Capital Fund · Last reported Apr 28, 2026$351MGross asset value

Form D fundraising filings

MPM BioVentures 2022, L.P.

Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG BOSTON, Massachusetts, United States
Custodian J.P. MORGAN SECURITIES LLC BOSTON, Massachusetts, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

J.P. MORGAN SECURITIES LLC
SEC 8-35008

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

Fund details & source
Fund ID
805-1480238338
Reported beneficial owners
47
Minimum commitment
$3M
Form D file number
021-444554

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

BIOIMPACT EQUITIES FUND, LPHedge Fund · Last reported Apr 28, 2026$312MGross asset value

Form D fundraising filings

BioImpact Equities Fund, LP

Fund administrator SS&C TECHNOLOGIES, INC. BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG BOSTON, Massachusetts, United States
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian JP MORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Fund details & source
Fund ID
805-1135587442
Reported beneficial owners
70
Minimum commitment
$1M
Form D file number
021-363866

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

MPM BIOIMPACT INNOVATIONS EQUITIES MASTER, LPHedge Fund · Last reported Apr 28, 2026$254MGross asset value

Form D fundraising filings

MPM BioImpact Innovations Equities Master, LP

Feeder funds

Fund administrator SS&C TECHNOLOGIES, INC BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG BOSTON, Massachusetts, United States
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian NORTHERN TRUST SECURITIES, INC. CHICAGO, Illinois, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

NORTHERN TRUST SECURITIES, INC.
SEC 8-23689

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Fund details & source
Fund ID
805-6920379274
Reported beneficial owners
15
Minimum commitment
$1M
Form D file number
021-517266
Form D file number
021-517386

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

NEW TECHNOLOGIES AND VIROLOGY FUND, L.P.Other Private Fund · Last reported Apr 28, 2026$140MGross asset value

Feeder funds

  • NEW TECHNOLOGIES AND VIROLOGY PRIVATE INVESTMENT FUND, L.P.
  • NEW TECHNOLOGIES AND VIROLOGY PUBLIC INVESTMENT FUND, L.P.
Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG GRAND CAYMAN, Cayman Islands
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Fund details & source
Fund ID
805-7291038561
Reported beneficial owners
6
Minimum commitment
$5M

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Apr 28, 2026. View historical filings

Reported services

Pooled investment vehicle management

Compensation

Percentage of assets · Performance-based

Principal office

399 BOYLSTON STREET, SUITE 1100
BOSTON, MA, 02116, United States

CRD 148467

Filing source

Form ADV 2098941 · Apr 28, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.